# RAFT - Pace &Ablate

Study · id `cardio:ct-nct06299514` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06299514](<https://clinicaltrials.gov/study/NCT06299514>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06299514

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

## Technical summary

Registry record NCT06299514. Randomized; single masking; primary purpose treatment. Start 2024-04-25 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT06299514, source copy `cardio:ctgov-nct06299514-2026-07-01`, retrieved 2026-10-26)
- Started: 2024-04-25 (actual) (ClinicalTrials.gov record NCT06299514, source copy `cardio:ctgov-nct06299514-2026-07-01`, retrieved 2026-10-26)
- Primary completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT06299514, source copy `cardio:ctgov-nct06299514-2026-07-01`, retrieved 2026-10-26)
- Completion: 2029-12-31 (anticipated) (ClinicalTrials.gov record NCT06299514, source copy `cardio:ctgov-nct06299514-2026-07-01`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT06299514, source copy `cardio:ctgov-nct06299514-2026-07-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06299514-2026-07-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: RAFT - Pace &Ablate
- Acronym: RAFT-P&A RCT
- Condition: Atrial Fibrillation
- Condition: Heart Failure
- Condition: Pacemaker
- Condition: Arrhythmia Atrial
- Intervention (Device): Pace and Ablate
- Intervention (Drug): Medication
- Lead sponsor: Habib Khan
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 47a533d7832873fd18b57c70915e7ad45dca12e3edc5c0d6fbb0d2d417899647
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
